Arbutus Biopharma Corporation ABUS
Set alert
4.00 USD -0.21 -4.99%
At close · Nov 2
3.96 -0.04 -1.00%
After hours · Nov 2, 5:40 PM ET
3.99 Day range 4.29
3.67 52-week range 5.22
- YTD
- -16.84%
- 1 year
- -15.43%
- Open
- 4.22
- Prev close
- 4.21
- Mkt cap
- 613.10M
- Vol
- 2.65M
- Avg vol
- 4.91M
- EPS
- 0.75
- P/E
- 5.33
- Div yield
- 0.00%
More statistics
- Low
- 3.99
- High
- 4.29
- Forward P/E
- -30.67
- Beta
- 0.62
- Short ratio
- 5.03
- Inst. own
- 72.71%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 16, 2026
- 50-d avg
- 4.79
- 200-d avg
- 4.52
- 1y target
- 5.46
30m chart
Built from the cached five-day intraday bars.
Signals (9)
| Name | Time | Ago |
|---|---|---|
| RSI: Oversold | Nov 2, 3:55 PM | 12 hours ago |
| MACD: Sell Signal | Nov 2, 3:25 PM | 12 hours ago |
| MACD: Buy Signal | Nov 2, 2:55 PM | 13 hours ago |
| MACD: Sell Signal | Nov 2, 11:25 AM | 16 hours ago |
| SMA: Bearish | Nov 2, 10:55 AM | 17 hours ago |
| MACD: Buy Signal | Nov 2, 9:55 AM | 18 hours ago |
| SMA: Bearish | Oct 29, 12:25 PM | 4 days ago |
| RSI: Overbought | Oct 28, 3:55 PM | 5 days ago |
| SMA: Bearish | Oct 28, 12:25 PM | 5 days ago |
Analyst view
Consensus: none
Price target (mean) 5.46
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 2
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.028 | -0.028 – -0.028 | -0.05601 | +50.0% | 1.39M | +87.4% | 1 |
| Next quarter | -0.028 | -0.028 – -0.028 | -0.01372 | -104.1% | 1.39M | -3.7% | 1 |
| Current year | 1.03 | 1.03 – 1.03 | -0.23321 | +540.4% | 252.84M | +1208.8% | 1 |
| Next year | -0.111 | -0.111 – -0.111 | 1.03 | -110.8% | 5.69M | -97.8% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Aug 11, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Mar 28, 2025 | Chardan Capital | Maintained | Buy | Buy |
| Jan 21, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 20, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 18, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 6, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Sep 5, 2024 | Jefferies | Maintained | Buy | Buy |
| Aug 2, 2024 | JMP Securities | Maintained | Market Outperform | Market Outperform |
| Jun 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 6, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 5, 2024 | Chardan Capital | Maintained | Buy | Buy |
| May 3, 2024 | Chardan Capital | Reiterated | Buy | Buy |
| Apr 4, 2024 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Mar 1, 2024 | Chardan Capital | Reiterated | Buy | Buy |
| Mar 1, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 12, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 4, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 4, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| Jul 11, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 6, 2023 | JMP Securities | Reiterated | Market Outperform | Market Outperform |
| Jun 22, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 22, 2023 | Chardan Capital | Reiterated | Buy | Buy |
| May 5, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 28, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Apr 5, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 29, 2023 | JMP Securities | Reiterated | — | Market Outperform |
| Mar 20, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 3, 2023 | Chardan Capital | Reiterated | — | Buy |